The quality analysis of Adverse Drug reaction reports in Shanghai during 2003-2007

Pharmaceutical Care and Research

Volumn 8, Issue 4, 2008, Pages 276-280

  Cheng, Wen ^a   Li, Yong Chang ^a   Fu, Zheng ^a   Wang, Hai Nan ^a   He, Jia ^a   Yu, De Lin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adverse drug reaction reporting systems; Data interpretation; Shanghai; Statistical

Indexed keywords

ARTICLE; CHINA; DRUG INDUSTRY; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; INCIDENT REPORT; MEDICAL EDUCATION; PUBLIC HOSPITAL; QUALITY CONTROL; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 52149092177     PISSN: 16712838     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Meyboom R H B, Egberts A C G, Gribnau F W J, et al. Pharmacovigilance in perspective[J]. Drug Saf, 1999,21(6): 429-447.
2. Morrison Griffiths S, Walley T J, Park B K, et al. Reporting of adverse drug reactions by nurses[J]. Lancet, 2003, 361 (9366):1347-1348.
3. Ulfvarson J, Mejyr S, Bergman U. Nurses are increasingly involved in pharmacovigilance in Sweden[J]. Pharmacoepidemiol Drug Saf, 2007, 16(5):532-537.
4. Bäckström M, Ekman E, Mjörndal T. Adverse drug reaction reporting by nurses in Sweden[J]. Eur J Clin Pharmacol, 2007, 63(6):613-618.
5. Chinese source.
6. Sills J M, Tanner L A, Milstien J B. Food and Drug Administration monitoring of adverse drug reactions[J]. Am J Hosp Pharm, 1986,43(11):2764-2770.
7. Strom B L. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: a counterpoint [J]. JAMA, 2004, 292(21):2643-2646.
8. Chinese source.
9. Chinese source.
10. Chinese source.